Un-Audited Financial Result For The Quarter And Half Yearly Ended 30Th September, 2026
Filed with BSE · · 15 pages · English
Summary by 6ix AI
Bacil Pharma Ltd has reported the outcome of its board meeting held on a specific date, where the board approved the unaudited financial results for the half year and quarter ended on a specific date, along with the limited review report from the statutory auditors. The financial results will be submitted separately in the prescribed format as per regulations. The meeting commenced and concluded within a specified timeframe.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
On 6ix: 6ix.com/news/un-audited-financial-result-for-the-quarter-and-half-yearly-ended-30th-september-2026
Earlier from Bacil Pharma
- Board Meeting Outcome for Outcome Of Board Meeting Held On 14Th October, 2026
- Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
- Board Meeting Intimation for We Wish To Inform That The Meeting Of The Board Of Directors Of The Company Is Scheduled To Be Held On Wednesday, 14Th October, 2026
- Bacil Pharma Ltd Press Release Sep 26 2026
- Bacil Pharma Ltd Press Release Aug 31 2026
Follow Bacil Pharma into a list and get an email when it puts out news.
Follow Bacil Pharma